Truist raised the firm’s price target on National Health Investors to $58 from $55 and keeps a Hold rating on the shares. The company’s Q4 felt like an “inflection point”, with favorable occupancy and rent trends, and it appears poised to pursue acquisition opportunities, the analyst tells investors in a research note. Truist adds that it projects a 2.3% average annual FFO growth for the REIT over the next five years.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NHI:
- National Health upgraded to Outperform from Market Perform at BMO Capital
- Seeking up to 8.5% Dividend Yield? Well Fargo Suggests 2 Dividend Stocks to Buy
- National Health Investors Sets Executive Golden Parachutes
- Wedbush upgrades National Health on sanguine skilled nursing outlook
- Wells upgrades National Health Investors to Overweight, raises target to $63
